Which of the following is commonly used to manage chronic stable asthma?

Long-acting beta agonists (LABAs) are commonly used to manage chronic stable asthma because they provide extended bronchodilation, which helps to control asthma symptoms over a longer period. These medications work by stimulating beta-2 adrenergic receptors in the lungs, leading to relaxation of smooth muscle in the airways and improved airflow. LABAs are typically prescribed in combination with inhaled corticosteroids to enhance the overall management of asthma by reducing inflammation while also preventing the occurrence of asthma attacks.

In contrast, short-acting beta agonists are primarily used as rescue medications for acute asthma symptoms rather than for long-term control. Anticholinergics have a role in specific cases, especially for individuals with both asthma and chronic obstructive pulmonary disease (COPD), but they are not as commonly used in the routine management of stable asthma alone. Oral antibiotics are not indicated for asthma management unless there is a concurrent bacterial infection, making them irrelevant for the ongoing control of chronic asthma. Thus, LABAs are the most appropriate choice for managing chronic stable asthma effectively.